AI In-Brief

Thailand News in Brief

Thai PBS World

Thailand and the world, every day

AI can make mistakes. Please double-check.

Thailand’s efficacy tests on Favipiravir cannot be compared with those done in the Americas - Medical Services Department

14 Sept 02:39 Key points summarised by AI

Thailand's Medical Services Department asserts that Favipiravir efficacy tests in Thailand and the Americas are incomparable due to significant differences in methodology.
American tests featured a high proportion of obese and elderly patients, delayed drug administration, unadjusted dosages, and relied on patient self-assessment for efficacy.
Conversely, Thai tests involved younger, healthier patients, early Favipiravir administration, and showed half of the treated patients recovered significantly faster (within 2 days compared to 14 days for the control group).
Despite faster recovery in some Thai patients, the drug did not reduce viral load or accelerate virus disappearance in either group, though it was found to be safe.

Yesterday 09:24 Key points summarised by AI

Thailand secured a US$200 million loan from the World Bank to significantly invest in clean energy and low-carbon urban development initiatives.
The program aims to drive clean energy funding and low-carbon growth, ensuring a just transition for small and medium-sized enterprises, workers, farmers, and local communities.
Channelled through the Export-Import Bank of Thailand, the loan will fund energy efficiency upgrades in public buildings and industrial areas, including rooftop solar installations and electrical system modernizations, reducing initial capital burdens via Energy Service Companies (ESCOs).